Establishment, Characterization and Comparison of Seven Authentic Anaplastic Thyroid Cancer Cell Lines Retaining Clinical Features of the Original Tumors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
http://link.springer.com/content/pdf/10.1007/s00268-013-2409-7.pdf
Reference32 articles.
1. Smallridge RC (2012) Approach to the patient with anaplastic thyroid carcinoma. J Clin Endocrinol Metab 97:2566–2572
2. Akaishi J, Sugino K, Kitagawa W et al (2011) Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid 21:1183–1189
3. Sugitani I, Miyauchi A, Sugino K et al (2012) Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg 36:1247–1254. doi: 10.1007/s00268-012-1437-z
4. Cabanillas ME, Waguespack SG, Bronstein Y et al (2010) Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. J Clin Endocrinol Metab 95:2588–2595
5. Benvenga S (2011) Emerging therapies in sight for the fight against dedifferentiated thyroid cancer. J Clin Endocrinol Metab 96:347–350
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. TARGETED THERAPY OF ANAPLASTIC THYROID CANCER;Eastern Ukrainian Medical Journal;2023
2. Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management;Cancers;2022-12-28
3. Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells;Cancer Science;2022-07-12
4. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity;The Journal of Clinical Endocrinology & Metabolism;2021-06-19
5. Longitudinal assessment of B-RAF V595E levels in the peripheral cell-free tumor DNA of a 10-year-old spayed female Korean Jindo dog with unresectable metastatic urethral transitional cell carcinoma for monitoring the treatment response to a RAF inhibitor (sorafenib);Veterinary Quarterly;2021-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3